医療用漢方エキス製剤に関する研究 医療用葛根湯エキス製剤及び小青竜湯エキス製剤中の有効成分含有量

書誌事項

タイトル別名
  • A Study on Ethical Kampo Formulation Medicines. Contents of Acffve Ingredients of Ethical Kakkon-to and Sho-seiryu-to Extract Preparations.
  • Contents of Active Ingredients of Ethical Kakkon-to and Sho-seiryu-to Extract Preparations
  • 医療用葛根湯エキス製剤及び小青竜湯エキス製剤中の有効成分含有量

この論文をさがす

抄録

The contents of glycyrrhizin, paeoniflorin, and ephedrine as common indicator components to commercially available kakkon-to and Sho-seiryu-to extract preparations were determined. In addition, the content of the active ingredient schizandrin of known pharmacological action in the Sho-seiryu-to extract preparations was also determined. The contents of glycyrrhizin, paeoniflorin, and ephedrine varied from one brand to another of the kakkon-to and Sho-seiryu-to extract preparations (p<0.01). The content of paeoniflorin, in particular, in the kakkon-to extract preparations widely ranged from 37.3 mg to 75.2mg (p<0.01). The content of ephedrine in these some preparations also markedly ranged from 8.5mg to 20.9mg (p<0.01). On the other hand, the content of ephedrine in the Sho-seiryu-to extract preparations markedly changed from lot to lot with some brands.<BR>The content of schizandrin showed a pronounced variation among brands of these preparations (p<0.01). These results indicate the need for establishing proper standards of formulation medicines and the specification of the content of active ingredients other than the indicator components.

収録刊行物

  • 病院薬学

    病院薬学 22 (5), 473-481, 1996

    一般社団法人 日本医療薬学会

参考文献 (15)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ